Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Depression and its associated factors among people who use drugs attending the Methadone Treatment Clinic at Tumbi Hospital in Pwani, Tanzania: A cross-sectional study
- Charle A.C. , et al.
2. Medicaid And Methadone For Opioid Use Disorder: Expanded Coverage Increased Distribution In 10 States, 2019–24
- Latsko E. , et al.
3. A Discrete-Choice Experiment to Assess Patient Preferences for Long-Acting Injectable Treatments in Opioid Use Disorder in Australia, Finland, Germany, and Italy
- Kabra M. , et al.
4. Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country
- Tantuoyir M.M. , et al.
5. The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder
- Callister C. , et al.
6. Novel Uses of Methadone Under the "72-Hour Rule" to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic
- Shahlapour M. , et al.
7. Male patients’ preferences for opioid use treatment programs
- Amini-Rarani M. , et al.
8. Medication for opioid use disorder in the Arab World: A systematic review
- Alawa J. , et al.
9. Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis
- Shayan S.J. , et al.
10. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis
- Rajabi A. , et al.
11. Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule
- Laks J. , et al.
12. Optimizing hepatitis C virus (HCV) treatment in a US colocated HCV/opioid agonist therapy program
- Habchi J. , et al.
13. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
- Ekhtiari H. , et al.
14. Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics
- Taylor L.E. , et al.
16. The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden
- Zhang L. , et al.
17. Correlation between interleukin-6 levels and methadone maintenance therapy outcomes
- Lu R.B. , et al.
18. Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
- Calcaterra S.L. , et al.
19. Medical complications of opioid use disorder in pregnancy
- Prasad M. , et al.
20. The Global State of Harm Reduction in Prisons
- Sander G. , et al.
21. Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users
- Sheikh M. , et al.
22. DOES IT WORK?-a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China
- Zhang J.Y. , et al.
23. Barriers to progressing through a methadone maintenance treatment programme: Perspectives of the clients in the Mid-West of Ireland's drug and alcohol services
- Moran L. , et al.